Tocilizumab mono therapy versus other biologic mono therapy in RA

• Research type

  Research Study

• Full title

  Retrospective observational study investigating the efficacy of tocilizumab mono therapy versus other biologic mono therapy in the first line biologic position for patients with Rheumatoid Arthritis (RA).

• IRAS ID

  208049

• Contact name

  Theresa Barnes

• Contact email

  theresa.barnes@nhs.net

• Sponsor organisation

  Countess of Chester Hospital

• Duration of Study in the UK

  0 years, 4 months, 4 days

• Research summary

  This is a retrospective observational study looking at patients with rheumatoid arthritis. We plan to compare the use of Tocilizumab mono therapy to other biologic agents as monotherapy in patients who were previously naive to biologic therapy. We will assess pre disease scores and inflammatory markers and post treatment disease scores and inflammatory markers. We hope this will help guide our biologic prescribing in the future.

• REC name

  London - Stanmore Research Ethics Committee

• REC reference

  16/LO/1336

• Date of REC Opinion

  5 Sep 2016

• REC opinion

  Further Information Favourable Opinion